<DOC>
	<DOCNO>NCT02515292</DOCNO>
	<brief_summary>Purpose : Clinical assessment ( anthropometric ) paraclinical ( biochemical immunological dose serum insuline growth factor IGF1 IGF2 receptor ) neonates intrauterine growth restriction ( IUGR ) integration multidimensional statistical model . Objectives : 1 . IGF1 IGF2 evaluation serum IGF1 receptor , IGF2 receptor IGF2 receptor gene expression cord blood newborn intrauterine growth restriction ( IUGR ) . ( Prospective ) 2 . Evaluation monitoring anthropometric , clinical ( non-cardiac morbidity ) paraclinical . ( Retrospective &amp; prospective ) 3 . Evaluation monitor morphological functional echocardiography . ( Prospective ) 4 . Integrating multidimensional clinical paraclinical parameter statistical model evaluate newborn intrauterine growth restriction .</brief_summary>
	<brief_title>Evaluation Infants With Intrauterine Growth Restriction</brief_title>
	<detailed_description />
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<criteria>newborn intrauterine growth restriction ( IUGR ) : weight 10th percentile gestational age parental consent enrollment IUGR neonates context chromosomopathies : trisomy 21 , trisomy 18. neonate congenital heart disease twin refusal parent participation study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Hours</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>IUGR ( intrauterine growth restriction )</keyword>
	<keyword>IGF2 ( insulin-like growth factor 2 )</keyword>
	<keyword>morbidity</keyword>
</DOC>